Get Cash Back and $0 Commissions + The Power of TradeStation
Xenetic Biosciences, Inc. Presents Positive Data Demonstrating DNase I Significantly Improves Efficacy of Anti-CTLA-4 Immune Checkpoint Blockade in Preclinical Colorectal Carcinoma Models
ACCESSWIRE 12-Nov-2024 9:02 AM
Data presented at Society for Immunotherapy of Cancer (SITC) 2024
